Lupin has introduced generic nystatin and triamcinolone acetonide cream, which had a market value of $54.3 million, according to IQVIA data for the 12 months ended September 2018.
Lupin received FDA approval for generic Anafranil capsules, and generic potassium chloride oral solution, which had a market value of about $109.6 million, and $105 million, respectively.
Following a court ruling in its favor, Dr. Reddy's will resume launch activities for its generic Suboxone sublingual film, which provides a treatment for opioid addiction.